Fig. 3From: Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains frameworkSummary by year indicating percentage of participants who specified neuroprotection/brain protection, reductions in cerebral palsy and death as benefits of antenatal magnesium sulphateBack to article page